The Cocktail Report (sound really smart around your friends):
UCLA researchers followed 92 adults over 60 with diagnosed insomnia disorder for roughly two years, comparing cognitive behavioral therapy for insomnia (CBT-I, a structured talk therapy that retrains sleep habits and thinking patterns) against a sleep education course
Biological aging was measured with DunedinPACE, an epigenetic clock that reads chemical tags on DNA to estimate how fast someone is aging, expressed as biological years gained per calendar year
The CBT-I group aged 0.02 years per year slower than the education group, a statistically significant difference
Here is the detail that matters most: the therapy group stayed flat, while the education group's pace of aging significantly accelerated. The benefit came from preventing decline, not reversing it
People whose insomnia never went into remission showed the steepest acceleration of all, which points to the sleep problem itself as the driver
If you have ever lain awake at 3 a.m. doing math on how little sleep you are about to get, this study is about you. It is the first randomized trial to show that treating insomnia changes a measurable marker of how fast your body is aging.
The trial randomly assigned older adults with insomnia disorder to one of two eight-week group programs. One was CBT-I, the other was sleep education covering sleep hygiene and stress biology.
Blood was drawn before treatment and again about two years later. Researchers then ran three epigenetic clocks on those samples.
Only one of the three clocks, DunedinPACE, showed a significant effect. GrimAge and PCPhenoAge both moved in the favorable direction but did not reach statistical significance.
The reason DunedinPACE likely picked up what the others missed is that it was built to detect change within the same person over time. The other two clocks were designed to predict long-term outcomes like mortality, which makes them less sensitive over a two-year window.
Now the part most coverage will skip. The therapy group's own change over two years was not statistically significant, a decline of 0.01 that could be noise.
What was significant was the education group getting worse, with a 0.03 increase in pace of aging. So the accurate reading is that untreated insomnia accelerated biological aging, and treatment prevented that acceleration.
The remission data supports this. CBT-I produced full remission in 34% of participants versus 13% on education alone, and the people whose insomnia persisted showed the largest aging acceleration of any group.
A word of caution on size and scope. This was 92 people at a single Los Angeles medical center, analyzed as a subset of a larger trial, with only 73% statistical power.
The two groups also differed in sex balance, 73% women in the education arm versus 45% in the therapy arm, which the researchers adjusted for but could not fully rule out as a factor. The authors are direct that replication in larger trials is needed.
What makes this worth your attention anyway is accessibility. CBT-I requires no prescription and no supplement; it is the standard first-line insomnia treatment, and it is available through therapists and validated apps.
Why Should You Care?
If you have chronic insomnia, this suggests the cost is not just fatigue but a measurably faster rate of biological aging. The encouraging part is that insomnia is one of the more treatable problems in medicine, and fixing it appears to stop that acceleration.
1. Carroll JE, Kusters CD, Taha HB, Olmstead R, Breen EC, Irwin MR. "Cognitive behavioural therapy for insomnia and epigenetic ageing: secondary analysis from a randomised controlled trial." The Lancet Healthy Longevity, Volume 7, Issue 7, Article 100861, July 2026. https://www.thelancet.com/journals/lanhl/article/PIIS2666-7568(26)00045-0/fulltext
2. DOI: 10.1016/j.lanhl.2026.100861 — https://doi.org/10.1016/j.lanhl.2026.100861
3. Parent trial registration: ClinicalTrials.gov NCT01641263 https://clinicaltrials.gov/study/NCT01641263
